While FAT1 upregulation has been shown to promote cancers of liver, brain, breast, colon, and pancreas; mutations in FAT1 have been found to promote skin, lung, head and neck and oral cancers. This evidence concerns the gene FAT1 and lip and oral cavity carcinoma.